T1	Participants 270 342	in patients affected by cervical cancer undergoing radical hysterectomy.
T2	Participants 351 445	Consecutive patients affected by stage IB-IIB cervical carcinoma scheduled for radical surgery
T3	Participants 465 496	Patients were randomly assigned
T4	Participants 591 644	All patients underwent classical radical hysterectomy
T5	Participants 772 802	168 patients entered the study
